drugset / Trial / NCT02528175
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This pilot study hypothesizes that hyperthermia delivered via magnetic resonance-guided focused ultrasound (MRg-FU) is technically feasible and can be safely used in combination with concurrent reirradiation and chemotherapy for the treatment of recurrent rectal cancer. Twenty recurrent rectal cancer patients who are not candidates for surgery will be recruited for hyperthermia treatment delivered via MRg-FU concurrent with reirradiation and oral chemotherapy.
Timeline
- Start
- 2015-04
- Primary completion
- 2021-04
- Completion
- 2022-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Capecitabine | Small molecule | — | Oral |